Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhangjiagang Cpolymer Eco-Technologies is a biotechnology company specializing in advanced polymer-based drug delivery systems and high-end pharmaceutical excipients. The company focuses on the development and manufacturing of ionizable lipids, lipid nanoparticles (LNPs), and other polymeric carriers essential for nucleic acid therapeutics, including mRNA vaccines and siRNA treatments. Cpolymer provides integrated solutions ranging from R&D to large-scale production, supporting global pharmaceutical partners in the field of gene therapy and precision medicine. Their expertise lies in optimizing the stability and delivery efficiency of complex biologics. Headquartered in Zhangjiagang, China, the company operates state-of-the-art facilities to ensure high-quality standards for the global market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhangjiagang Cpolymer Eco-Technologies.